Centiva Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

Centiva Capital’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-35,000	Closed	-$2.09M	–	1042
2019 Q4	$2.09M	Buy	+35,000	New	+$1.31M	0.1%	191

Centiva Capital's BOLD Position: Q1 2020 in Review

Centiva Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 35,000 shares — an estimated $2.09M sold.

Centiva Capital first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $2.09M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Centiva Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Centiva Capital sold 35,000 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $2.09M.
Centiva Capital first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Centiva Capital's Audentes Therapeutics, Inc position peaked at $2.09M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Centiva Capital's 13F filing for Q1 2020, filed 15 May 2020.